The U.S. Pharmacogenomics Market report focuses on the varying dynamics of the pharmacogenomics market. This report covers the Pharmacogenomics services, Gene-based Diagnostics, and Orphan Drugs segments. This report provides an in-depth analysis of the revenue sales forecasts for the market, drivers and restraints that affect the current and future markets, industry challenges and strategies, competitive, pricing and demand analysis and market and technology trends. The base year for this report is 2000.
Market Overview
- Pharmacogenomics and Polymorphisms
- The Advantages of Pharmacogenomics
- Market for Pharmacogenomics
Analysis by Major Segments
- Overview
- Service Market of Pharmacogenomics
- Diagnostics
- Orphan Drugs
- Overall Trends
- Competitive Analysis
- Technologies
Research and Scope
Methodology and Definitions
- Objectives and Validation
- Structure and Segmentation
- Forecast Period - Milestones
Total Market Analysis
- Research Methodology
- List of Definitions
- List of Acronyms
Conclusion
- Market Overview
- Market Challenges
- Market Drivers
- Market Restraints
- Market Forecast
Market Engineering Awards
- Recommendations
- Concluding Remarks
Service Market
Microarrays Market
Bioinformatics Market
Present Status of Diagnostics in Pharmacogenomics
Future Status for Diagnostics in Pharmacogenomics
Background
The Present Market for Orphan Drugs
The Future for Orphan Drugs
Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
The U.S. Pharmacogenomics Market report focuses on the varying dynamics of the pharmacogenomics market. This report covers the Pharmacogenomics services, Gene-based Diagnostics, and Orphan Drugs segments. This report provides an in-depth analysis of the revenue sales forecasts for the market, drivers and restraints that affect the current and future markets, industry challenges and strategies, competitive, pricing and demand analysis and market and technology trends. The base year for this report is 2000.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | 7965-01-00-00-00 |
| Is Prebook | No |
U.S. Pharmacogenomics Markets
U.S. Pharmacogenomics Markets
RELEASE DATE
06-Jun-2001
06-Jun-2001
REGION
North America
North America
Deliverable Type
Market Research
Market Research
Research Code: 7965-01-00-00-00
SKU: HC00378-NA-MR_03582
$3,950.00
In stock
SKU
HC00378-NA-MR_03582